ClinicalTrials.gg
Not yet recruitingNCT07808996Updated Sep 9, 2026

Prospective Agreement Study of Magnetic Resonance Imaging Measurements and Intraoperative Dimensions During Gluteal Permanent Synthetic Filler Removal

An observational study in Gluteal Tissue Ischemia Risk, Foreign-Body Reaction and Soft Tissue Filler Complication, sponsored by Research Inc. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Research Inc · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
220
Ages
18 Years and older
Sex
All
01

Study summary

This prospective agreement study will compare preoperative MRI measurements with direct surgical measurements in adults undergoing removal of gluteal tissue affected by permanent synthetic fillers. MRI will estimate affected-tissue dimensions and residual skin-flap thickness at predefined landmarks. During surgery, the same flap landmarks and the fresh excised specimen will be measured. The primary outcome is agreement between MRI and intraoperative flap thickness; postoperative ischemia, wound dehiscence, and necrosis will be followed through 30 days.

Read the detailed description

Participants will receive standardized preoperative MRI morphometric mapping within 90 days before surgery. Two trained readers will measure the affected tissue block in three axes, estimate its volume, and record residual flap thickness at predefined surface landmarks. During the index filler-removal procedure, the landmarks will be reproduced and measured directly with a calibrated sterile device. The fresh specimen will be oriented, measured, and weighed before fixation. Agreement, bias, and prediction error will be quantified. Clinical follow-up through day 30 will determine whether thinner flaps or larger prediction errors are associated with ischemia-related wound complications.

02

Conditions studied

  • Gluteal Tissue Ischemia Risk
  • Foreign-Body Reaction
  • Soft Tissue Filler Complication

Keywords

  • Gluteal Reconstruction
  • Specimen Measurement
  • Flap Thickness
  • Surgical Planning
  • Magnetic Resonance Imaging
  • Biopolymers
03

In context

Lead sponsor

Research Inc is the lead sponsor of 24 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults scheduled for surgical excision of gluteal tissue affected by permanent synthetic fillers after preoperative MRI.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Gluteal permanent synthetic filler disease scheduled for elective surgical excision.
  • Preoperative MRI performed within 90 days before surgery using the study measurement protocol.
  • Planned skin/subcutaneous flap elevation that permits direct thickness measurement at predefined landmarks.
  • Written .

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery or active uncontrolled infection that prevents standardized preoperative imaging or measurement.
  • Prior surgery causing loss of the predefined landmarks or making paired measurement impossible.
  • Nondiagnostic MRI or incomplete coverage of the planned operative field.
  • Specimen fragmentation that prevents standardized fresh-specimen dimension measurement for the secondary endpoint.
  • Inability to complete 30-day wound follow-up.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
220 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • MRI-to-Surgery Agreement Cohort (Cohort)

    Participants undergo preoperative MRI morphometry followed by standardized intraoperative flap and specimen measurements during clinically indicated filler removal.

    Diagnostic Test: Preoperative MRI Morphometric Mapping · Procedure: Standardized Intraoperative and Fresh-Specimen Measurement

Interventions

  • Diagnostic testPreoperative MRI Morphometric Mapping

    Three orthogonal dimensions of the affected block and residual flap thickness at fixed surface landmarks will be measured on MRI by two trained readers. Affected-tissue volume will be estimated using segmentation when available and a prespecified geometric approximation otherwise. Linked arm/group(s): MRI-to-Surgery Agreement Cohort.

  • ProcedureStandardized Intraoperative and Fresh-Specimen Measurement

    Before closure, residual flap thickness will be measured with a calibrated sterile device at the same mapped landmarks without compressing the tissue. The fresh excised block will be oriented and measured in three axes before fixation. Specimen weight will also be recorded. Linked arm/group(s): MRI-to-Surgery Agreement Cohort.

06

What researchers measure

Primary outcomes

  1. Agreement Between MRI and Intraoperative Residual Flap Thickness

    Residual skin-subcutaneous flap thickness in millimeters will be measured at predefined mapped landmarks on MRI and directly during surgery. Agreement will be summarized using intraclass correlation, mean bias, 95% limits of agreement, and absolute error.

    Time frame: Preoperative MRI within 90 days before surgery and the index surgical procedure. 90 days

Secondary outcomes

  1. Agreement Between MRI and Fresh-Specimen Affected-Tissue Dimensions

    Maximum craniocaudal, mediolateral, and anteroposterior dimensions in centimeters will be compared between MRI and the oriented fresh specimen before fixation.

    Time frame: Preoperative MRI within 90 days before surgery and immediately after specimen removal during the index operation. 90 days

  2. Absolute Percentage Error in Predicted Affected-Tissue Volume

    Absolute difference between MRI-predicted and specimen-derived volume divided by specimen-derived volume and multiplied by 100. Lower values indicate more accurate prediction.

    Time frame: Preoperative MRI and the index surgical procedure. 1 day

  3. Incidence of Ischemic Wound Complications

    Proportion of participants with clinically documented flap ischemia, partial- or full-thickness tissue necrosis, or wound dehiscence judged to be related to tissue perfusion.

    Time frame: From surgery through postoperative day 30. 30 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — patient consent signed before do not take in account share the information on that way

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07808996
Lead sponsor
Research Inc
Responsible party
Sponsor
First posted
Sep 9, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Oct 1, 2026 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Sep 9, 2026

Study contacts

Edison Osorio, MD, Plastic surgeon
Contact
info@edisonosorio.com
+573226140611
Edison Osorio, MD, plastic surgery
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion